2022 - Research.com Medicine in Portugal Leader Award
His scientific interests lie mostly in Pathology, Thyroid, Carcinoma, Thyroid carcinoma and Cancer research. His Pathology research incorporates elements of Stomach and Germline mutation. His biological study spans a wide range of topics, including Differential diagnosis, Adenoma and Vimentin.
The various areas that Manuel Sobrinho-Simões examines in his Carcinoma study include Retrospective cohort study, Cancer, Single-strand conformation polymorphism and Microsatellite instability. Manuel Sobrinho-Simões combines subjects such as Follicular phase, Thyroid cancer and Adenocarcinoma with his study of Thyroid carcinoma. His study in Cancer research is interdisciplinary in nature, drawing from both Mutation, Gene, Carcinogenesis and Exon.
Pathology, Thyroid, Thyroid carcinoma, Cancer research and Carcinoma are his primary areas of study. As part of one scientific family, Manuel Sobrinho-Simões deals mainly with the area of Pathology, narrowing it down to issues related to the Calcitonin, and often Medullary carcinoma. His studies deal with areas such as Cell and Adenoma as well as Thyroid.
His work in Thyroid carcinoma addresses subjects such as Thyroid cancer, which are connected to disciplines such as Anatomical pathology and Malignancy. He usually deals with Cancer research and limits it to topics linked to Carcinogenesis and Molecular biology. His studies in Carcinoma integrate themes in fields like Cancer, Adenocarcinoma, Thyroid tumors and Microsatellite instability.
His main research concerns Thyroid, Pathology, Thyroid carcinoma, Thyroid cancer and Cancer research. His Thyroid study combines topics from a wide range of disciplines, such as Differential diagnosis and Calcitonin. His study looks at the intersection of Pathology and topics like Cell with Lymphoma and Phenotype.
His Thyroid carcinoma study combines topics in areas such as Cancer, Osteopontin and Follicular phase. His Thyroid cancer study also includes
His primary areas of study are Thyroid carcinoma, Thyroid, Pathology, Thyroid cancer and Internal medicine. His work carried out in the field of Thyroid carcinoma brings together such families of science as Carcinoma, Lymph node and Thyroglobulin. His Thyroid research integrates issues from Carcinogenesis, Cell culture, Melanoma and Mitochondrion.
His work deals with themes such as Cell, Follicular phase, Metastasis and Familial adenomatous polyposis, which intersect with Pathology. Manuel Sobrinho-Simões has researched Thyroid cancer in several fields, including Cancer research, Thyroid nodules and mitochondrial fusion, MFN2, FIS1. Immunohistochemistry and Neuroblastoma RAS viral oncogene homolog is closely connected to Endocrinology in his research, which is encompassed under the umbrella topic of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Frequency of TERT promoter mutations in human cancers.
João Vinagre;Ana Almeida;Ana Almeida;Helena Pópulo;Rui Batista.
Nature Communications (2013)
BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
Paula Soares;Vítor Trovisco;Ana Sofia Rocha;Jorge Lima.
Helicobacter pylori and Interleukin 1 Genotyping: An Opportunity to Identify High-Risk Individuals for Gastric Carcinoma
Céu Figueiredo;José Carlos Machado;Paul Pharoah;Raquel Seruca.
Journal of the National Cancer Institute (2002)
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma
José Carlos Machado;Céu Figueiredo;Paulo Canedo;Paul Pharoah.
Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.
Marco Volante;Paola Collini;Yuri E. Nikiforov;Atsuhiko Sakamoto.
The American Journal of Surgical Pathology (2007)
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma
Ricardo V Lloyd;Lori A Erickson;Mary B Casey;King Y Lam.
The American Journal of Surgical Pathology (2004)
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo;Miguel Melo;Adriana Gaspar da Rocha;Adriana Gaspar da Rocha;João Vinagre;João Vinagre;Rui Batista.
The Journal of Clinical Endocrinology and Metabolism (2014)
BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
Vítor Trovisco;Inês Vieira de Castro;Paula Soares;Paula Soares;Valdemar Máximo.
The Journal of Pathology (2004)
Intestinal Metaplasia of Human Stomach Displays Distinct Patterns of Mucin (MUC1, MUC2, MUC5AC, and MUC6) Expression
C A Reis;L David;P Correa;F Carneiro.
Cancer Research (1999)
PAX8-PPARγ rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma
P. Castro;A. P. Rebocho;R. J. Soares;J. Magalhães.
The Journal of Clinical Endocrinology and Metabolism (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: